Leave a request
MindMaze, a global leader in brain technology, and Mount Sinai Health System, the largest academic medical system in New York City, today announced an innovative at home tele-neurorehabilitation program for stroke patients, utilizing the FDA-cleared and CE-marked MindMotion GO™. With this first-of-its-kind mobile neurorehabilitation therapy system from MindMaze, patients can continue their recovery at home with virtual support from clinicians at Mount Sinai’s Abilities Research Center (ARC). This initiative expands patient access to MindMotion GO, which has been adopted by the Rehabilitation Innovation team at Mount Sinai since June to provide critical neurorehabilitation across the continuum of care.
With the COVID-19 pandemic impacting all aspects of public health, including limiting patients’ access to important rehabilitation intervention, access to tele-neurorehabilitation has never been more essential. Using MindMaze’s gamified digital therapy program, Mount Sinai patients can seamlessly transition between inpatient to outpatient rehabilitation and continue their recovery at home while still receiving support and care from their physical therapists. Designed to keep acute and chronic stroke patients training for longer periods, MindMotion GO guides a complete range of body parts including the upper and lower limbs, hands, and trunk, to improve motor and task functions.
Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt.
With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality and artificial intelligence, we have enhanced the recovery potential of patients with neurological diseases. Combining our FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI and cloud technologies, our goal is to create the universal platform for brain health.
Expanding our impact beyond healthcare, MindMaze Labs is our enterprising R&D division tasked with bringing our ground-breaking neuroscience to everyday life. By harnessing the power of the brain, our neurotechnology will empower the next generation of human-machine interfaces.
In less than ten years, we have transformed care for debilitating neurological diseases. Our plans for the next ten years are just as ambitious.
The article was prepared based on the information: MindMaze
Leave a request